Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37142825)

  • 21. Combination of SLC administration and Tregs depletion is an attractive strategy for targeting hepatocellular carcinoma.
    Chen L; Zhou S; Qin J; Hu H; Ma H; Liu B; Wang X; Ma J; Ye S; Zhong C; Zhou G; Liang C
    Mol Cancer; 2013 Dec; 12(1):153. PubMed ID: 24304581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.
    Li F; Guo Z; Lizée G; Yu H; Wang H; Si T
    Clin Chem Lab Med; 2014 Sep; 52(9):1357-65. PubMed ID: 24646790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses.
    Chew V; Lai L; Pan L; Lim CJ; Li J; Ong R; Chua C; Leong JY; Lim KH; Toh HC; Lee SY; Chan CY; Goh BKP; Chung A; Chow PKH; Albani S
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):E5900-E5909. PubMed ID: 28674001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GPC3-IL7-CCL19-CAR-T primes immune microenvironment reconstitution for hepatocellular carcinoma therapy.
    Lu LL; Xiao SX; Lin ZY; Bai JJ; Li W; Song ZQ; Zhou YH; Lu B; Wu WZ
    Cell Biol Toxicol; 2023 Dec; 39(6):3101-3119. PubMed ID: 37853185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced frequency and functional defects of CD4
    Luo L; Zeng X; Huang Z; Luo S; Qin L; Li S
    Reprod Biol Endocrinol; 2020 Jun; 18(1):62. PubMed ID: 32522204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NLRP6 deficiency suppresses colorectal cancer liver metastasis growth by modulating M-MDSC-induced immunosuppressive microenvironment.
    Chang L; Xu L; Tian Y; Liu Z; Song M; Li S; Zhang X; Chen Y; Hao Q; Lu Y; Zhen Y
    Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167035. PubMed ID: 38278335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased prevalence of regulatory T cells in the tumor microenvironment and its correlation with TNM stage of hepatocellular carcinoma.
    Shen X; Li N; Li H; Zhang T; Wang F; Li Q
    J Cancer Res Clin Oncol; 2010 Nov; 136(11):1745-54. PubMed ID: 20221638
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The frequency, phenotypes and functions of CD4+ CD25+ regulatory T cells in hepatocellular carcinoma patients].
    Zhang HH; Fei R; Mei MH; Liao WJ; Wang XY; Cong X; Qin LL; Ji Y; Wang SX; Wei L; Chen HS
    Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):266-72. PubMed ID: 17456313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myeloid derived suppressor cells in peripheral blood can be a prognostic factor in canine transitional cell carcinoma.
    Yokota S; Yonezawa T; Momoi Y; Maeda S
    Vet Immunol Immunopathol; 2024 Mar; 269():110716. PubMed ID: 38308864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma.
    Lee WC; Wu TJ; Chou HS; Yu MC; Hsu PY; Hsu HY; Wang CC
    Surgery; 2012 Feb; 151(2):213-22. PubMed ID: 21975289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Diagnostic Value of Chemokine/Chemokine Receptor Pairs in Hepatocellular Carcinoma and Colorectal Liver Metastasis.
    Jiao X; Shu G; Liu H; Zhang Q; Ma Z; Ren C; Guo H; Shi J; Liu J; Zhang C; Wang Y; Gao Y
    J Histochem Cytochem; 2019 May; 67(5):299-308. PubMed ID: 30633620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes of regulatory T cells and FoxP3 gene expression in the aging process and its relationship with lung tumors in humans and mice.
    Pan XD; Mao YQ; Zhu LJ; Li J; Xie Y; Wang L; Zhang GB
    Chin Med J (Engl); 2012 Jun; 125(11):2004-11. PubMed ID: 22884069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasound-targeted microbubble destruction-mediated Foxp3 knockdown may suppress the tumor growth of HCC mice by relieving immunosuppressive Tregs function.
    Shi C; Zhang Y; Yang H; Dong T; Chen Y; Xu Y; Yang X; Liu P
    Exp Ther Med; 2018 Jan; 15(1):31-38. PubMed ID: 29387180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma and macrophage interaction induced tumor immunosuppression via Treg requires TLR4 signaling.
    Yang J; Zhang JX; Wang H; Wang GL; Hu QG; Zheng QC
    World J Gastroenterol; 2012 Jun; 18(23):2938-47. PubMed ID: 22736917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective recruitment of regulatory T cell through CCR6-CCL20 in hepatocellular carcinoma fosters tumor progression and predicts poor prognosis.
    Chen KJ; Lin SZ; Zhou L; Xie HY; Zhou WH; Taki-Eldin A; Zheng SS
    PLoS One; 2011; 6(9):e24671. PubMed ID: 21935436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Shedding LIGHT (TNFSF14) on the tumor microenvironment of colorectal cancer liver metastases.
    Qin JZ; Upadhyay V; Prabhakar B; Maker AV
    J Transl Med; 2013 Mar; 11():70. PubMed ID: 23514280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of CD4+CD25+CD127
    Zhou W; Deng J; Chen Q; Li R; Xu X; Guan Y; Li W; Xiong X; Li H; Li J; Cai X
    Int J Med Sci; 2020; 17(6):712-719. PubMed ID: 32218692
    [No Abstract]   [Full Text] [Related]  

  • 38. Direct and Indirect Effect of TGFβ on Treg Transendothelial Recruitment in HCC Tissue Microenvironment.
    Dituri F; Mancarella S; Serino G; Chaoul N; Lupo LG; Villa E; Fabregat I; Giannelli G
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.
    Liu M; Zhou J; Liu X; Feng Y; Yang W; Wu F; Cheung OK; Sun H; Zeng X; Tang W; Mok MTS; Wong J; Yeung PC; Lai PBS; Chen Z; Jin H; Chen J; Chan SL; Chan AWH; To KF; Sung JJY; Chen M; Cheng AS
    Gut; 2020 Feb; 69(2):365-379. PubMed ID: 31076403
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activated hepatic stellate cells regulate MDSC migration through the SDF-1/CXCR4 axis in an orthotopic mouse model of hepatocellular carcinoma.
    Xu Y; Fang F; Jiao H; Zheng X; Huang L; Yi X; Zhao W
    Cancer Immunol Immunother; 2019 Dec; 68(12):1959-1969. PubMed ID: 31641797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.